Gritstone bio (NASDAQ:GRTS) Receives Neutral Rating from HC Wainwright
HC Wainwright restated their neutral rating on shares of Gritstone bio (NASDAQ:GRTS – Free Report) in a report published on Tuesday, MarketBeat reports. They currently have a $0.50 price target on the stock, down from their previous price target of $4.00. Separately, JMP Securities cut Gritstone bio from an outperform rating to a market perform […]
More Stories
REGENXBIO Inc. (NASDAQ:RGNX) Given Consensus Rating of “Moderate Buy” by Analysts
REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings...
Transocean (NYSE:RIG) PT Raised to $6.00 at Morgan Stanley
Transocean (NYSE:RIG – Get Free Report) had its price target increased by stock analysts at Morgan Stanley from $5.00 to...
Devon Energy (NYSE:DVN) Coverage Initiated at Jefferies Financial Group
Equities research analysts at Jefferies Financial Group started coverage on shares of Devon Energy (NYSE:DVN – Get Free Report) in...
Bank OZK (NASDAQ:OZKAP) Announces Quarterly Dividend of $0.29
Bank OZK (NASDAQ:OZKAP – Get Free Report) declared a quarterly dividend on Thursday, October 3rd, Wall Street Journal reports. Stockholders...
AngioDynamics (NASDAQ:ANGO) Issues FY 2025 Earnings Guidance
AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of...
RTX (NYSE:RTX) Rating Increased to Hold at Deutsche Bank Aktiengesellschaft
RTX (NYSE:RTX – Get Free Report) was upgraded by equities researchers at Deutsche Bank Aktiengesellschaft from a “sell” rating to...